ENDSULIN
Business Services · Wisconsin, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1206 Sherman Ave, Madison, Wisconsin, 53...Phone Number
(608) 285-2070Website
www.endsulin.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ENDSULIN
Endsulin is a biotechnology company based in Madison, WI, focused on developing a revolutionary genetic therapy for Type 1 Diabetes (T1DM). Their proprietary technology aims to re-engineer liver cells to enable the body to produce and regulate its own insulin, potentially providing long-term freedom from artificial insulin dependence. Founded by a renowned scientist and transplant surgeon, the company seeks to deliver a simple infusion treatment that eliminates the need for immunosuppressive agents. Endsulin's innovative approach is designed to reshape diabetes treatment and fulfill the goal of independence from the daily burden of diabetes.Explore more
ENDSULIN Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ENDSULIN your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at ENDSULIN
Website visits: Recent activity has been detected on your website
Check out if ENDSULIN is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once ENDSULIN has new funding data
Earning: See what the market has to say on ENDSULIN recently announced quarterly report
Product Launch: Get notified when ENDSULIN launches new products
ENDSULIN, which may be a good buyer, showed buying intent in Masked Content Topic
Check if ENDSULIN has recently received funding, and reach out quickly before it becomes old news!
Click to see if ENDSULIN had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined ENDSULIN as Masked Content
Find 2 more new buyers
Compare Similar Companies to ENDSULIN
Compare insights from companies similar to ENDSULIN, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
2016
KC
Kellie CalderonDivision Clinical Development Vice President, Medical Affairs
Company Profile Activity
Activity Insights
ENDSULIN is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ENDSULIN is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ENDSULIN.
ENDSULIN Tech Stack
A closer look at the technologies used by ENDSULIN
See more technologies
ENDSULIN News & Media
Top Executives from AveXis Join New Gene Therapy Venture -- This Time Targeting Tens of Millions More Patients
MADISON, Wis., March 29, 2021 /PRNewswire/ -- A pair of top C-level Executives from blockbuster gene therapy company AveXis have joined ENDSULIN, a new venture that could reach millions more than any gene therapy to date. Spearheaded by one of the disease's most accomplished pioneers, the...Diabetic Dogs Needed for Study that Could Reduce or Eliminate Insulin Injections
MADISON, Wis., March 16, 2021 /PRNewswire/ -- Gene therapy company ENDSULIN is looking for diabetic dogs to participate in a study to evaluate the effectiveness of a treatment that could reduce or even eliminate insulin injections. The study could be a critical step in advancing a...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding ENDSULIN
Sign Up For FreeTo access detailed company insights
Endsulin is a biotechnology company based in Madison, WI, focused on developing a revolutionary genetic therapy for Type 1 Diabetes (T1DM). Their proprietary technology aims to re-engineer liver cells to enable the body to produce and regulate its own insulin, potentially providing long-term freedom from artificial insulin dependence. Founded by a... Read More
